Education
About Us
Working with TipRanks
Follow Us
Biocardia (BCDA)
:BCDA
Total Valuation
BioCardia has a market cap or net worth of $8.24M. The enterprise value is $8.61M.
Market Cap$8.24M
Enterprise Value$8.61M
Share Statistics
BioCardia has 4,680,005 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,680,005
Owned by Insiders21.67%
Owned by Institutions0.56%
Financial Efficiency
BioCardia’s return on equity (ROE) is -9.49 and return on invested capital (ROIC) is -447.48%.
Return on Equity (ROE)-9.49
Return on Assets (ROA)-2.13
Return on Invested Capital (ROIC)-447.48%
Return on Capital Employed (ROCE)-5.70
Revenue Per Employee3.41K
Profits Per Employee-467.41K
Employee Count17
Asset Turnover0.02
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of BioCardia is -0.75. BioCardia’s PEG ratio is 0.01.
PE Ratio-0.75
PS Ratio171.75
PB Ratio7.15
Price to Fair Value7.15
Price to FCF-0.74
Price to Operating Cash Flow-0.75
PEG Ratio0.01
Income Statement
In the last 12 months, BioCardia had revenue of 58.00K and earned -7.95M in profits. Earnings per share was -2.90.
Revenue58.00K
Gross Profit58.00K
Operating Income-8.00M
Pretax Income-7.95M
Net Income-7.95M
EBITDA-7.93M
Earnings Per Share (EPS)-2.90
Cash Flow
In the last 12 months, operating cash flow was -8.03M and capital expenditures -6.00K, giving a free cash flow of -8.03M billion.
Operating Cash Flow-8.03M
Free Cash Flow-8.03M
Free Cash Flow per Share-1.72
Dividends & Yields
BioCardia pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.01
52-Week Price Change-67.03%
50-Day Moving Average2.33
200-Day Moving Average2.49
Relative Strength Index (RSI)36.94
Average Volume (3m)72.41K
Important Dates
BioCardia upcoming earnings date is May 7, 2025, TBA Not Confirmed.
Last Earnings DateMar 26, 2025
Next Earnings DateMay 7, 2025
Ex-Dividend Date―
Financial Position
BioCardia as a current ratio of 1.13, with Debt / Equity ratio of 113.62%
Current Ratio1.13
Quick Ratio1.13
Debt to Market Cap0.16
Net Debt to EBITDA0.18
Interest Coverage Ratio0.00
Taxes
In the past 12 months, BioCardia has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
BioCardia EV to EBITDA ratio is -0.57, with an EV/FCF ratio of -0.57.
EV to Sales78.65
EV to EBITDA-0.57
EV to Free Cash Flow-0.57
EV to Operating Cash Flow-0.57
Balance Sheet
BioCardia has $2.37M in cash and marketable securities with $951.00K in debt, giving a net cash position of -$1.42M billion.
Cash & Marketable Securities$2.37M
Total Debt$951.00K
Net Cash-$1.42M
Net Cash Per Share-$0.30
Tangible Book Value Per Share$0.31
Margins
Gross margin is -265.52%, with operating margin of -13794.83%, and net profit margin of -13700.00%.
Gross Margin-265.52%
Operating Margin-13794.83%
Pretax Margin-13700.00%
Net Profit Margin-13700.00%
EBITDA Margin-13679.31%
EBIT Margin-13794.83%
Analyst Forecast
The average price target for BioCardia is $6.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$6.00
Price Target Upside222.58% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-87.84%
EPS Growth Forecast59.34%